194 related articles for article (PubMed ID: 23962256)
1. Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.
Shimada K; Serada S; Fujimoto M; Nomura S; Nakatsuka R; Harada E; Iwahori K; Tachibana I; Takahashi T; Kumanogoh A; Kishimoto T; Naka T
Cancer Sci; 2013 Nov; 104(11):1483-91. PubMed ID: 23962256
[TBL] [Abstract][Full Text] [Related]
2. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.
Souma Y; Nishida T; Serada S; Iwahori K; Takahashi T; Fujimoto M; Ripley B; Nakajima K; Miyazaki Y; Mori M; Doki Y; Sawa Y; Naka T
Int J Cancer; 2012 Sep; 131(6):1287-96. PubMed ID: 22095154
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.
Lin YC; Lin CK; Tsai YH; Weng HH; Li YC; You L; Chen JK; Jablons DM; Yang CT
Oncol Rep; 2010 Dec; 24(6):1605-12. PubMed ID: 21042758
[TBL] [Abstract][Full Text] [Related]
5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
6. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral Delivery of an Adenoviral Vector Carrying the
Nakagawa S; Serada S; Kakubari R; Hiramatsu K; Sugase T; Matsuzaki S; Matsuzaki S; Ueda Y; Yoshino K; Ohkawara T; Fujimoto M; Kishimoto T; Kimura T; Naka T
Mol Cancer Ther; 2018 Sep; 17(9):1941-1950. PubMed ID: 29891489
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.
Tagami-Nagata N; Serada S; Fujimoto M; Tanemura A; Nakatsuka R; Ohkawara T; Murota H; Kishimoto T; Katayama I; Naka T
Exp Dermatol; 2015 Nov; 24(11):864-71. PubMed ID: 26173926
[TBL] [Abstract][Full Text] [Related]
9. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
10. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
Wang X; Chen Z
Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells.
Yamamoto M; Nishimoto N; Davydova J; Kishimoto T; Curiel DT
Cancer Gene Ther; 2006 Feb; 13(2):194-202. PubMed ID: 16082380
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
[TBL] [Abstract][Full Text] [Related]
14. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
[TBL] [Abstract][Full Text] [Related]
15. Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer.
Muhammad T; Sakhawat A; Khan AA; Huang H; Khan HR; Huang Y; Wang J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):861-874. PubMed ID: 32088783
[TBL] [Abstract][Full Text] [Related]
16. Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.
Dragoj M; Bankovic J; Sereti E; Stojanov SJ; Dimas K; Pesic M; Stankovic T
Invest New Drugs; 2017 Dec; 35(6):718-732. PubMed ID: 28733702
[TBL] [Abstract][Full Text] [Related]
17. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.
Huang FJ; Steeg PS; Price JE; Chiu WT; Chou PC; Xie K; Sawaya R; Huang S
Cancer Res; 2008 Dec; 68(23):9634-42. PubMed ID: 19047140
[TBL] [Abstract][Full Text] [Related]
19. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]